Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)

NCT06331884 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety and Tolerability
Healthy Volunteers

Interventions

DRUG: AK1967 (Procizumab)
DRUG: Placebo

Sponsor

4TEEN4 Pharmaceuticals GmbH